BBIO
NASDAQStockBridgeBio Pharma, Inc.
$68.82-2.76 (-3.87%)
52-Week Range
$30.14
$79.91
Key Stats
Market Cap
13.3B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.18
Volume
1.6M
Avg Volume
3.3M
Performance
1M
-1.49%
3M
-5.00%
6M
+38.70%
YTD
-8.75%
1Y
+119.05%
3Y
+391.33%
5Y
+2.15%
Price Chart
ETF Exposure
BBIO is held by 120 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| QQJG | Invesco ESG NASDAQ Next Gen 100 ETF | 0.24% |
| URTY | ProShares - UltraPro Russell2000 | 0.23% |
| BBMC | JPMorgan BetaBuilders U.S. Mid Cap Equity ETF | 0.22% |
| BKMC | BNY Mellon US Mid Cap Core Equity ETF | 0.22% |
| SMLF | iShares U.S. Small-Cap Equity Factor ETF | 0.22% |
| FAD | First Trust Multi Cap Growth AlphaDEX Fund | 0.21% |
| GSSC | Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF | 0.19% |
| ISCB | iShares Morningstar Small-Cap ETF | 0.18% |
| JKJ | iShares Morningstar Small-Cap ETF | 0.18% |
| PRFZ | Invesco RAFI US 1500 Small-Mid ETF | 0.18% |
| TNXT | T. Rowe Price Innovation Leaders ETF | 0.18% |
| VB | Vanguard Small-Cap ETF | 0.18% |
| VHT | Vanguard Health Care ETF | 0.17% |
| FHLC | FIDELITY MSCI HEALTH CARE INDEX ETF | 0.17% |
| SCDS | JPMorgan Fundamental Data Science Small Core ETF | 0.17% |
| ESML | iShares ESG Aware MSCI USA Small-Cap ETF | 0.17% |
| VXF | Vanguard Extended Market ETF | 0.17% |
| AVIE | Avantis Inflation Focused Equity ETF | 0.15% |
| JHMH | John Hancock Multifactor Health Care ETF | 0.11% |
| WSML | iShares MSCI World Small-Cap ETF | 0.10% |
| PTL | Inspire 500 ETF | 0.10% |
| SMMD | iShares Russell 2500 ETF | 0.09% |
| GTPE | Goldman Sachs MSCI World Private Equity Return Tracker ETF | 0.08% |
| JHMM | John Hancock Investments - Multifactor Mid Cap ETF | 0.07% |
| HDG | ProShares - Hedge Replication ETF | 0.06% |
| XT | iShares Future Exponential Technologies ETF | 0.06% |
| IALT | iShares Systematic Alternatives Active ETF | 0.05% |
| AVUQ | Avantis U.S. Quality ETF | 0.04% |
| ONEQ | FIDELITY NASDAQ COMPOSITE INDEX ETF | 0.04% |
| STXG | Strive 1000 Growth ETF | 0.03% |
| SPGM | State Street SPDR Portfolio MSCI Global Stock Market ETF | 0.03% |
| STSB | iShares Factors US Small Blend Style ETF | 0.03% |
| DCOR | Dimensional - US Core Equity 1 ETF | 0.03% |
| TILT | FlexShares Morningstar U.S. Market Factor Tilt Index Fund | 0.03% |
| ESGV | Vanguard ESG U.S. Stock ETF | 0.02% |
| DFAU | Dimensional - US Core Equity Market ETF | 0.02% |
| OMFS | Invesco Russell 2000 Dynamic Multifactor ETF | 0.02% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 0.02% |
| SCHK | Schwab 1000 Index ETF | 0.02% |
| VTI | Vanguard Total Stock Market ETF | 0.02% |
| SCHB | Schwab U.S. Broad Market ETF | 0.02% |
| IWV | iShares Russell 3000 ETF | 0.02% |
| VTHR | Vanguard Russell 3000 ETF | 0.02% |
| AVLC | Avantis U.S. Large Cap Equity ETF | 0.02% |
| DFUS | Dimensional - US Equity Market ETF | 0.02% |
| V3AL.L | Vanguard ESG Global All Cap UCITS ETF (USD) Distributing | 0.01% |
| DFAC | Dimensional - US Core Equity 2 ETF | 0.01% |
| GUSA | Goldman Sachs MarketBeta US 1000 Equity ETF | 0.01% |
| VT | Vanguard Total World Stock ETF | 0.01% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.01% |
About BBIO ETF Exposure
BridgeBio Pharma, Inc. (BBIO) is held by 120 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 13.3B, BBIO is a widely held institutional stock. The stock currently trades at $68.82. Investors can gain exposure to BBIO through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold BBIO, sorted by portfolio weight.